Alentemol Explained

Alentemol (INN) (developmental code name U-66444B), or alentamol, is a selective dopamine autoreceptor agonist described as an antipsychotic, which was never marketed.[1] [2]

Notes and References

  1. Book: William Andrew Publishing. Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. 22 October 2013. Elsevier. 978-0-8155-1856-3. 143–.
  2. Book: A.F. Casy. The Steric Factor in Medicinal Chemistry: Dissymmetric Probes of Pharmacological Receptors. 11 November 2013. Springer Science & Business Media. 978-1-4899-2397-4. 178–.